IMMUNOTHERAPEUTIC AGENT FOR CANCER CONTAINING NUCLEOIDAL COMPONENT OF BACTERIUM AS ACTIVE INGREDIENT

摘要

An agent for cancer immunotherapy with independent use, containing bacterial components as an active ingredient, which induces cancer patients to exhibit immune responsiveness, as indicated by the increase of interferon- gamma and CD28 markers in peripheral blood, when administered to an immuno-competent patient intracutaneously.